Search Browse Earnings

Ernexa Therapeutics Inc. — SlamSEC

Ernexa Therapeutics Inc.

Nasdaq:ERNANasdaq:ERNAW

Pharmaceutical Preparations·CAMBRIDGE, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$19.8M

-15.1% YoY

FY 2020

Adj. EBITDA

-$21.1M

-106.3% margin

FY 2024

Net Income

-$21.7M

-109.4% margin

FY 2024

EPS (Diluted)

-$4.08

FY 2024

Stock Price

$0.29

-5.8%

2026-03-06

52W Range

$0.27 – $4.28

P/E Ratio

-0.1x

Market Cap

$2.3M

Cash

$7.6M

FY 2024

Total Debt

$532,000

FY 2020

Net Cash

$7.0M

FY 2020

Enterprise Value

-$4.8M

Debt / EBITDA

0.3x

FY 2020

EV / EBITDA

0.2x

Employees

—